These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 21688390)
1. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. Kim YH; Jeon J; Hong SH; Rhim WK; Lee YS; Youn H; Chung JK; Lee MC; Lee DS; Kang KW; Nam JM Small; 2011 Jul; 7(14):2052-60. PubMed ID: 21688390 [TBL] [Abstract][Full Text] [Related]
2. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression. Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and Bioevaluation of Iodine-131 Directly Labeled Cyclic RGD-PEGylated Gold Nanorods for Tumor-Targeted Imaging. Zhang Y; Zhang Y; Yin L; Xia X; Hu F; Liu Q; Qin C; Lan X Contrast Media Mol Imaging; 2017; 2017():6081724. PubMed ID: 29434531 [TBL] [Abstract][Full Text] [Related]
5. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
6. A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword. Shuhendler AJ; Prasad P; Leung M; Rauth AM; Dacosta RS; Wu XY Adv Healthc Mater; 2012 Sep; 1(5):600-8. PubMed ID: 23184795 [TBL] [Abstract][Full Text] [Related]
7. Multiphoton-absorption-induced-luminescence (MAIL) imaging of tumor-targeted gold nanoparticles. Dowling MB; Li L; Park J; Kumi G; Nan A; Ghandehari H; Fourkas JT; DeShong P Bioconjug Chem; 2010 Nov; 21(11):1968-77. PubMed ID: 20964333 [TBL] [Abstract][Full Text] [Related]
8. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors. Xiong L; Chen Z; Tian Q; Cao T; Xu C; Li F Anal Chem; 2009 Nov; 81(21):8687-94. PubMed ID: 19817386 [TBL] [Abstract][Full Text] [Related]
9. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells. Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336 [TBL] [Abstract][Full Text] [Related]
10. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery. Yu MK; Park J; Jeong YY; Moon WK; Jon S Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354 [TBL] [Abstract][Full Text] [Related]
11. Tumor Angiogenesis Targeted Radiosensitization Therapy Using Gold Nanoprobes Guided by MRI/SPECT Imaging. Yang Y; Zhang L; Cai J; Li X; Cheng D; Su H; Zhang J; Liu S; Shi H; Zhang Y; Zhang C ACS Appl Mater Interfaces; 2016 Jan; 8(3):1718-32. PubMed ID: 26731347 [TBL] [Abstract][Full Text] [Related]
12. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles. Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214 [TBL] [Abstract][Full Text] [Related]
13. Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging. Zako T; Nagata H; Terada N; Utsumi A; Sakono M; Yohda M; Ueda H; Soga K; Maeda M Biochem Biophys Res Commun; 2009 Mar; 381(1):54-8. PubMed ID: 19351594 [TBL] [Abstract][Full Text] [Related]
14. In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors. Jin ZH; Josserand V; Foillard S; Boturyn D; Dumy P; Favrot MC; Coll JL Mol Cancer; 2007 Jun; 6():41. PubMed ID: 17565663 [TBL] [Abstract][Full Text] [Related]
15. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model. Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145 [TBL] [Abstract][Full Text] [Related]
16. Molecular targeting radiotherapy with cyclo-RGDFK(C) peptides conjugated to 177Lu-labeled gold nanoparticles in tumor-bearing mice. Vilchis-Juárez A; Ferro-Flores G; Santos-Cuevas C; Morales-Avila E; Ocampo-García B; Díaz-Nieto L; Luna-Gutiérrez M; Jiménez-Mancilla N; Pedraza-López M; Gómez-Oliván L J Biomed Nanotechnol; 2014 Mar; 10(3):393-404. PubMed ID: 24730235 [TBL] [Abstract][Full Text] [Related]
17. Tumor Chemo-Radiotherapy with Rod-Shaped and Spherical Gold Nano Probes: Shape and Active Targeting Both Matter. Zhang L; Su H; Wang H; Li Q; Li X; Zhou C; Xu J; Chai Y; Liang X; Xiong L; Zhang C Theranostics; 2019; 9(7):1893-1908. PubMed ID: 31037146 [TBL] [Abstract][Full Text] [Related]
18. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins. Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054 [TBL] [Abstract][Full Text] [Related]
19. Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor. Adulnirath A; Chung SW; Park J; Hwang SR; Kim JY; Yang VC; Kim SY; Moon HT; Byun Y J Control Release; 2012 Nov; 164(1):8-16. PubMed ID: 23063549 [TBL] [Abstract][Full Text] [Related]
20. A multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin αvβ3 and tenascin-C proteins. Ko HY; Choi KJ; Lee CH; Kim S Biomaterials; 2011 Feb; 32(4):1130-8. PubMed ID: 21071077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]